|
|
 |
|
| | |
| | | | | |
modification
|
|
PR:000000575 |
smad2 isoform Short acetylated and phosphorylated form
|
SMAD2/iso:Short/AcPhos+
|
"A smad2 isoform Short that includes at least one acetylated residue and at least one phosphorylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | |
modification
|
|
PR:000000655 |
smad2 isoform Short acetylated and phosphorylated 1
|
SMAD2/iso:Short/AcPhos:1
|
"A smad2 isoform Short acetylated and phosphorylated form in which the phosphorylation occurs at the last two Ser residues within the SSxS C-terminal motif by TGF-beta pathway activation and acetylated in a Lys residue within the MH1 domain by coactivators, such as CBP, PCAF and EP300. Example: UniProtKB:Q15796-2, Lys-19, MOD:00064|Ser-435/Ser-437, MOD:00046." [PMID:17074756]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000036556 |
smad2 isoform Short acetylated and phosphorylated 1 (human)
|
hSMAD2/iso:Short/AcPhos:1
|
"A smad2 isoform Short acetylated and phosphorylated 1 in human. UniProtKB:Q15796-2, Lys-19, MOD:00064|Ser-435/Ser-437, MOD:00046." [PMID:17074756, PRO:CNA]
|
Yes |
|
|
|
|
